ONTOLOGY	ID	Description	GeneRatio	BgRatio	pvalue	p.adjust	qvalue	geneID	Count
KEGG	hsa04151	PI3K-Akt signaling pathway	13/134	354/8135	0.005442	0.8653	0.8653	IFNAR1/PPP2R5A/THEM4/FGF5/CCND2/PCK1/BDNF/DDIT4/EFNA5/PPP2R1B/EIF4EBP1/ATF4/THBS3	13
KEGG	hsa04310	Wnt signaling pathway	7/134	167/8135	0.02019	0.8653	0.8653	PLCB4/FZD10/CSNK2A2/CAMK2D/CCND2/DAAM1/TCF7L2	7
KEGG	hsa04925	Aldosterone synthesis and secretion	5/134	98/8135	0.02258	0.8653	0.8653	PLCB4/KCNK9/CAMK2D/KCNK3/ATF4	5
KEGG	hsa04720	Long-term potentiation	4/134	67/8135	0.02428	0.8653	0.8653	PLCB4/CAMK2D/RPS6KA1/ATF4	4
KEGG	hsa04916	Melanogenesis	5/134	101/8135	0.02534	0.8653	0.8653	PLCB4/FZD10/EDN1/CAMK2D/TCF7L2	5
KEGG	hsa04922	Glucagon signaling pathway	5/134	107/8135	0.03148	0.8653	0.8653	PLCB4/PHKG1/CAMK2D/PCK1/ATF4	5
KEGG	hsa04115	p53 signaling pathway	4/134	73/8135	0.03199	0.8653	0.8653	CHEK2/SHISA5/ADGRB1/CCND2	4
KEGG	hsa04934	Cushing syndrome	6/134	155/8135	0.04261	0.8653	0.8653	PLCB4/FZD10/CAMK2D/KCNK3/TCF7L2/ATF4	6
KEGG	hsa00280	Valine, leucine and isoleucine degradation	3/134	48/8135	0.04415	0.8653	0.8653	ACSF3/ABAT/ACAT1	3
KEGG	hsa05030	Cocaine addiction	3/134	49/8135	0.04649	0.8653	0.8653	PDYN/BDNF/ATF4	3
KEGG	hsa00900	Terpenoid backbone biosynthesis	2/134	22/8135	0.05019	0.8653	0.8653	PCYOX1/ACAT1	2
KEGG	hsa04142	Lysosome	5/134	132/8135	0.06656	0.8653	0.8653	HYAL1/AP1S3/CTSK/FUCA1/SMPD1	5
KEGG	hsa04728	Dopaminergic synapse	5/134	132/8135	0.06656	0.8653	0.8653	PLCB4/PPP2R5A/CAMK2D/PPP2R1B/ATF4	5
KEGG	hsa04978	Mineral absorption	3/134	60/8135	0.07594	0.8653	0.8653	HMOX1/MT1X/MT1F	3
KEGG	hsa00650	Butanoate metabolism	2/134	28/8135	0.07708	0.8653	0.8653	ABAT/ACAT1	2
KEGG	hsa05217	Basal cell carcinoma	3/134	63/8135	0.08511	0.8653	0.8653	FZD10/BMP4/TCF7L2	3
KEGG	hsa00020	Citrate cycle (TCA cycle)	2/134	30/8135	0.08686	0.8653	0.8653	ACO1/PCK1	2
KEGG	hsa00630	Glyoxylate and dicarboxylate metabolism	2/134	30/8135	0.08686	0.8653	0.8653	ACO1/ACAT1	2
KEGG	hsa04927	Cortisol synthesis and secretion	3/134	65/8135	0.09148	0.8653	0.8653	PLCB4/KCNK3/ATF4	3
KEGG	hsa00410	beta-Alanine metabolism	2/134	31/8135	0.09189	0.8653	0.8653	SMOX/ABAT	2
KEGG	hsa05165	Human papillomavirus infection	9/134	331/8135	0.09547	0.8653	0.8653	IFNAR1/TADA3/PPP2R5A/FZD10/CCND2/PPP2R1B/TCF7L2/EIF4EBP1/THBS3	9
KEGG	hsa04261	Adrenergic signaling in cardiomyocytes	5/134	150/8135	0.1014	0.8653	0.8653	PLCB4/PPP2R5A/CAMK2D/PPP2R1B/ATF4	5
KEGG	hsa04924	Renin secretion	3/134	69/8135	0.1048	0.8653	0.8653	PLCB4/PDE3A/EDN1	3
KEGG	hsa05031	Amphetamine addiction	3/134	69/8135	0.1048	0.8653	0.8653	CAMK2D/PDYN/ATF4	3
KEGG	hsa03008	Ribosome biogenesis in eukaryotes	4/134	109/8135	0.105	0.8653	0.8653	CSNK2A2/NOB1/NHP2/FBL	4
KEGG	hsa04066	HIF-1 signaling pathway	4/134	109/8135	0.105	0.8653	0.8653	HMOX1/EDN1/CAMK2D/EIF4EBP1	4
KEGG	hsa04520	Adherens junction	3/134	71/8135	0.1117	0.8653	0.8653	VCL/CSNK2A2/TCF7L2	3
KEGG	hsa04060	Cytokine-cytokine receptor interaction	8/134	295/8135	0.1134	0.8653	0.8653	TNFRSF11B/IFNAR1/TNFSF15/IL15RA/BMP4/IL13RA2/TNFRSF17/CXCL14	8
KEGG	hsa04150	mTOR signaling pathway	5/134	156/8135	0.1147	0.8653	0.8653	FZD10/PRR5/RPS6KA1/DDIT4/EIF4EBP1	5
KEGG	hsa04390	Hippo signaling pathway	5/134	157/8135	0.117	0.8653	0.8653	FZD10/BMP4/CCND2/PPP2R1B/TCF7L2	5
KEGG	hsa03320	PPAR signaling pathway	3/134	75/8135	0.1261	0.8653	0.8653	FABP3/PCK1/SLC27A2	3
KEGG	hsa04918	Thyroid hormone synthesis	3/134	75/8135	0.1261	0.8653	0.8653	PLCB4/ASGR1/ATF4	3
KEGG	hsa04971	Gastric acid secretion	3/134	76/8135	0.1297	0.8653	0.8653	PLCB4/KCNK10/CAMK2D	3
KEGG	hsa04071	Sphingolipid signaling pathway	4/134	119/8135	0.1328	0.8653	0.8653	PLCB4/PPP2R5A/PPP2R1B/SMPD1	4
KEGG	hsa04722	Neurotrophin signaling pathway	4/134	119/8135	0.1328	0.8653	0.8653	CAMK2D/RPS6KA1/BDNF/ATF4	4
KEGG	hsa04152	AMPK signaling pathway	4/134	120/8135	0.1358	0.8653	0.8653	PPP2R5A/PCK1/PPP2R1B/EIF4EBP1	4
KEGG	hsa05207	Chemical carcinogenesis - receptor activation	6/134	212/8135	0.137	0.8653	0.8653	ESR1/FGF5/RPS6KA1/GSTT2B/EIF4EBP1/ATF4	6
KEGG	hsa04919	Thyroid hormone signaling pathway	4/134	121/8135	0.1387	0.8653	0.8653	PLCB4/ESR1/BMP4/RCAN1	4
KEGG	hsa00860	Porphyrin metabolism	2/134	43/8135	0.1575	0.8694	0.8694	HMOX1/BLVRB	2
KEGG	hsa04911	Insulin secretion	3/134	86/8135	0.1686	0.8694	0.8694	PLCB4/CAMK2D/ATF4	3
KEGG	hsa04114	Oocyte meiosis	4/134	131/8135	0.1697	0.8694	0.8694	PPP2R5A/CAMK2D/RPS6KA1/PPP2R1B	4
KEGG	hsa00620	Pyruvate metabolism	2/134	47/8135	0.181	0.8694	0.8694	PCK1/ACAT1	2
KEGG	hsa00520	Amino sugar and nucleotide sugar metabolism	2/134	49/8135	0.193	0.8694	0.8694	NAGK/CYB5R2	2
KEGG	hsa04672	Intestinal immune network for IgA production	2/134	49/8135	0.193	0.8694	0.8694	IL15RA/TNFRSF17	2
KEGG	hsa05418	Fluid shear stress and atherosclerosis	4/134	139/8135	0.1961	0.8694	0.8694	HMOX1/EDN1/BMP4/GSTT2B	4
KEGG	hsa04912	GnRH signaling pathway	3/134	93/8135	0.1975	0.8694	0.8694	PLCB4/CAMK2D/ATF4	3
KEGG	hsa04140	Autophagy - animal	4/134	141/8135	0.2028	0.8694	0.8694	RAB39B/IGBP1/DDIT4/CFLAR	4
KEGG	hsa00330	Arginine and proline metabolism	2/134	51/8135	0.205	0.8694	0.8694	SMOX/CKM	2
KEGG	hsa03015	mRNA surveillance pathway	3/134	97/8135	0.2145	0.8694	0.8694	PPP2R5A/PPP2R1B/CPSF1	3
KEGG	hsa04961	Endocrine and other factor-regulated calcium reabsorption	2/134	53/8135	0.2171	0.8694	0.8694	PLCB4/ESR1	2
KEGG	hsa05131	Shigellosis	6/134	247/8135	0.2221	0.8694	0.8694	PLCB4/VCL/CGAS/ARF6/NAIP/SEPTIN6	6
KEGG	hsa05224	Breast cancer	4/134	147/8135	0.2236	0.8694	0.8694	FZD10/ESR1/FGF5/TCF7L2	4
KEGG	hsa00430	Taurine and hypotaurine metabolism	1/134	16/8135	0.2336	0.8694	0.8694	FMO2	1
KEGG	hsa05142	Chagas disease	3/134	102/8135	0.2363	0.8694	0.8694	PLCB4/PPP2R1B/CFLAR	3
KEGG	hsa01212	Fatty acid metabolism	2/134	57/8135	0.2415	0.8694	0.8694	ACSF3/ACAT1	2
KEGG	hsa00240	Pyrimidine metabolism	2/134	58/8135	0.2476	0.8694	0.8694	TYMP/AK9	2
KEGG	hsa04921	Oxytocin signaling pathway	4/134	154/8135	0.2485	0.8694	0.8694	RGS2/PLCB4/CAMK2D/RCAN1	4
KEGG	hsa04928	Parathyroid hormone synthesis, secretion and action	3/134	106/8135	0.2539	0.8694	0.8694	PLCB4/PTHLH/ATF4	3
KEGG	hsa05022	Pathways of neurodegeneration - multiple diseases	10/134	476/8135	0.2582	0.8694	0.8694	NDUFA4L2/PLCB4/FZD10/PSMB5/RAB39B/CSNK2A2/CAMK2D/PDYN/BDNF/ATF4	10
KEGG	hsa00061	Fatty acid biosynthesis	1/134	18/8135	0.2586	0.8694	0.8694	ACSF3	1
KEGG	hsa00511	Other glycan degradation	1/134	18/8135	0.2586	0.8694	0.8694	FUCA1	1
KEGG	hsa05160	Hepatitis C	4/134	157/8135	0.2593	0.8694	0.8694	IFNAR1/OCLN/PPP2R1B/CFLAR	4
KEGG	hsa04730	Long-term depression	2/134	60/8135	0.2599	0.8694	0.8694	PLCB4/PPP2R1B	2
KEGG	hsa04931	Insulin resistance	3/134	108/8135	0.2628	0.8694	0.8694	RPS6KA1/PCK1/SLC27A2	3
KEGG	hsa04217	Necroptosis	4/134	159/8135	0.2666	0.8694	0.8694	IFNAR1/CAMK2D/SMPD1/CFLAR	4
KEGG	hsa00531	Glycosaminoglycan degradation	1/134	19/8135	0.2709	0.8694	0.8694	HYAL1	1
KEGG	hsa01210	2-Oxocarboxylic acid metabolism	1/134	19/8135	0.2709	0.8694	0.8694	ACO1	1
KEGG	hsa04630	JAK-STAT signaling pathway	4/134	162/8135	0.2776	0.8694	0.8694	IFNAR1/IL15RA/IL13RA2/CCND2	4
KEGG	hsa04668	TNF signaling pathway	3/134	112/8135	0.2807	0.8694	0.8694	EDN1/CFLAR/ATF4	3
KEGG	hsa04929	GnRH secretion	2/134	64/8135	0.2844	0.8694	0.8694	TRPC4/PLCB4	2
KEGG	hsa04725	Cholinergic synapse	3/134	113/8135	0.2852	0.8694	0.8694	PLCB4/CAMK2D/ATF4	3
KEGG	hsa04670	Leukocyte transendothelial migration	3/134	114/8135	0.2897	0.8694	0.8694	RHOH/VCL/OCLN	3
KEGG	hsa04022	cGMP-PKG signaling pathway	4/134	167/8135	0.2961	0.8694	0.8694	RGS2/PLCB4/PDE3A/ATF4	4
KEGG	hsa05225	Hepatocellular carcinoma	4/134	168/8135	0.2998	0.8694	0.8694	FZD10/HMOX1/GSTT2B/TCF7L2	4
KEGG	hsa05221	Acute myeloid leukemia	2/134	67/8135	0.3027	0.8694	0.8694	TCF7L2/EIF4EBP1	2
KEGG	hsa03060	Protein export	1/134	23/8135	0.3179	0.8694	0.8694	IMMP2L	1
KEGG	hsa04964	Proximal tubule bicarbonate reclamation	1/134	23/8135	0.3179	0.8694	0.8694	PCK1	1
KEGG	hsa04917	Prolactin signaling pathway	2/134	70/8135	0.321	0.8694	0.8694	ESR1/CCND2	2
KEGG	hsa00982	Drug metabolism - cytochrome P450	2/134	72/8135	0.3331	0.8694	0.8694	GSTT2B/FMO2	2
KEGG	hsa04137	Mitophagy - animal	2/134	72/8135	0.3331	0.8694	0.8694	CSNK2A2/ATF4	2
KEGG	hsa05171	Coronavirus disease - COVID-19	5/134	232/8135	0.3355	0.8694	0.8694	RPS4Y2/RPS4Y1/IFNAR1/CFB/CGAS	5
KEGG	hsa04380	Osteoclast differentiation	3/134	128/8135	0.3531	0.8694	0.8694	TNFRSF11B/IFNAR1/CTSK	3
KEGG	hsa04926	Relaxin signaling pathway	3/134	129/8135	0.3576	0.8694	0.8694	PLCB4/EDN1/ATF4	3
KEGG	hsa00062	Fatty acid elongation	1/134	27/8135	0.3618	0.8694	0.8694	THEM4	1
KEGG	hsa05100	Bacterial invasion of epithelial cells	2/134	77/8135	0.3631	0.8694	0.8694	VCL/SEPTIN6	2
KEGG	hsa05412	Arrhythmogenic right ventricular cardiomyopathy	2/134	77/8135	0.3631	0.8694	0.8694	SGCA/TCF7L2	2
KEGG	hsa04068	FoxO signaling pathway	3/134	131/8135	0.3666	0.8694	0.8694	FBXO32/CCND2/PCK1	3
KEGG	hsa03018	RNA degradation	2/134	79/8135	0.375	0.8694	0.8694	CNOT3/CNOT6L	2
KEGG	hsa04270	Vascular smooth muscle contraction	3/134	134/8135	0.3801	0.8694	0.8694	PLCB4/AVP/EDN1	3
KEGG	hsa00983	Drug metabolism - other enzymes	2/134	80/8135	0.3809	0.8694	0.8694	TYMP/GSTT2B	2
KEGG	hsa04210	Apoptosis	3/134	136/8135	0.3891	0.8694	0.8694	CTSK/CFLAR/ATF4	3
KEGG	hsa05132	Salmonella infection	5/134	249/8135	0.3914	0.8694	0.8694	RHOH/SNX18/TCF7L2/ARF6/NAIP	5
KEGG	hsa04146	Peroxisome	2/134	82/8135	0.3926	0.8694	0.8694	MPV17/SLC27A2	2
KEGG	hsa05014	Amyotrophic lateral sclerosis	7/134	364/8135	0.3929	0.8694	0.8694	NDUFA4L2/ANXA7/PSMB5/RAB39B/HNRNPA3/ATF4/SRSF3	7
KEGG	hsa04910	Insulin signaling pathway	3/134	137/8135	0.3935	0.8694	0.8694	PHKG1/PCK1/EIF4EBP1	3
KEGG	hsa05135	Yersinia infection	3/134	137/8135	0.3935	0.8694	0.8694	ARHGEF28/RPS6KA1/ARF6	3
KEGG	hsa04144	Endocytosis	5/134	251/8135	0.398	0.8694	0.8694	ACAP1/CBLC/WASHC1/ARF6/AGAP4	5
KEGG	hsa04915	Estrogen signaling pathway	3/134	138/8135	0.398	0.8694	0.8694	PLCB4/ESR1/ATF4	3
KEGG	hsa05162	Measles	3/134	139/8135	0.4025	0.8694	0.8694	IFNAR1/CSNK2A2/CCND2	3
KEGG	hsa01232	Nucleotide metabolism	2/134	85/8135	0.4101	0.8694	0.8694	TYMP/AK9	2
KEGG	hsa04012	ErbB signaling pathway	2/134	85/8135	0.4101	0.8694	0.8694	CAMK2D/EIF4EBP1	2
KEGG	hsa00640	Propanoate metabolism	1/134	32/8135	0.4129	0.8694	0.8694	ABAT	1
KEGG	hsa04136	Autophagy - other	1/134	32/8135	0.4129	0.8694	0.8694	IGBP1	1
KEGG	hsa05017	Spinocerebellar ataxia	3/134	143/8135	0.4202	0.8694	0.8694	PLCB4/PSMB5/PDYN	3
KEGG	hsa05168	Herpes simplex virus 1 infection	9/134	495/8135	0.4296	0.8694	0.8694	ZNF551/ZNF154/IFNAR1/ZNF404/BST2/ZNF552/EIF4EBP1/CGAS/SRSF3	9
KEGG	hsa00040	Pentose and glucuronate interconversions	1/134	34/8135	0.4321	0.8694	0.8694	XYLB	1
KEGG	hsa04211	Longevity regulating pathway	2/134	89/8135	0.4329	0.8694	0.8694	EIF4EBP1/ATF4	2
KEGG	hsa04727	GABAergic synapse	2/134	89/8135	0.4329	0.8694	0.8694	ABAT/SLC38A5	2
KEGG	hsa05235	PD-L1 expression and PD-1 checkpoint pathway in cancer	2/134	89/8135	0.4329	0.8694	0.8694	CSNK2A2/BATF	2
KEGG	hsa03040	Spliceosome	3/134	147/8135	0.4377	0.8694	0.8694	DHX8/HNRNPA3/SRSF3	3
KEGG	hsa05410	Hypertrophic cardiomyopathy	2/134	90/8135	0.4385	0.8694	0.8694	SGCA/EDN1	2
KEGG	hsa04072	Phospholipase D signaling pathway	3/134	148/8135	0.4421	0.8694	0.8694	PLCB4/AVP/ARF6	3
KEGG	hsa05226	Gastric cancer	3/134	149/8135	0.4465	0.8694	0.8694	FZD10/FGF5/TCF7L2	3
KEGG	hsa00512	Mucin type O-glycan biosynthesis	1/134	36/8135	0.4508	0.8694	0.8694	GALNT9	1
KEGG	hsa00250	Alanine, aspartate and glutamate metabolism	1/134	37/8135	0.4599	0.8694	0.8694	ABAT	1
KEGG	hsa01250	Biosynthesis of nucleotide sugars	1/134	37/8135	0.4599	0.8694	0.8694	NAGK	1
KEGG	hsa04960	Aldosterone-regulated sodium reabsorption	1/134	37/8135	0.4599	0.8694	0.8694	NR3C2	1
KEGG	hsa05143	African trypanosomiasis	1/134	37/8135	0.4599	0.8694	0.8694	PLCB4	1
KEGG	hsa05216	Thyroid cancer	1/134	37/8135	0.4599	0.8694	0.8694	TCF7L2	1
KEGG	hsa04350	TGF-beta signaling pathway	2/134	94/8135	0.4608	0.8694	0.8694	BMP4/PPP2R1B	2
KEGG	hsa05340	Primary immunodeficiency	1/134	38/8135	0.4688	0.8694	0.8694	RFXANK	1
KEGG	hsa04218	Cellular senescence	3/134	156/8135	0.4765	0.8694	0.8694	CHEK2/CCND2/EIF4EBP1	3
KEGG	hsa04713	Circadian entrainment	2/134	97/8135	0.4771	0.8694	0.8694	PLCB4/CAMK2D	2
KEGG	hsa05215	Prostate cancer	2/134	97/8135	0.4771	0.8694	0.8694	TCF7L2/ATF4	2
KEGG	hsa04750	Inflammatory mediator regulation of TRP channels	2/134	98/8135	0.4825	0.8694	0.8694	PLCB4/CAMK2D	2
KEGG	hsa00260	Glycine, serine and threonine metabolism	1/134	40/8135	0.4862	0.8694	0.8694	GCAT	1
KEGG	hsa04933	AGE-RAGE signaling pathway in diabetic complications	2/134	100/8135	0.4931	0.8694	0.8694	PLCB4/EDN1	2
KEGG	hsa03440	Homologous recombination	1/134	41/8135	0.4947	0.8694	0.8694	SYCP3	1
KEGG	hsa04216	Ferroptosis	1/134	41/8135	0.4947	0.8694	0.8694	HMOX1	1
KEGG	hsa05219	Bladder cancer	1/134	41/8135	0.4947	0.8694	0.8694	TYMP	1
KEGG	hsa04024	cAMP signaling pathway	4/134	221/8135	0.4963	0.8694	0.8694	PDE3A/EDN1/CAMK2D/BDNF	4
KEGG	hsa05166	Human T-cell leukemia virus 1 infection	4/134	222/8135	0.4998	0.8694	0.8694	CHEK2/IL15RA/CCND2/ATF4	4
KEGG	hsa00380	Tryptophan metabolism	1/134	42/8135	0.5031	0.8694	0.8694	ACAT1	1
KEGG	hsa05146	Amoebiasis	2/134	102/8135	0.5037	0.8694	0.8694	PLCB4/VCL	2
KEGG	hsa05163	Human cytomegalovirus infection	4/134	225/8135	0.5104	0.8694	0.8694	PLCB4/EIF4EBP1/CGAS/ATF4	4
KEGG	hsa00071	Fatty acid degradation	1/134	43/8135	0.5113	0.8694	0.8694	ACAT1	1
KEGG	hsa04975	Fat digestion and absorption	1/134	43/8135	0.5113	0.8694	0.8694	ACAT1	1
KEGG	hsa04064	NF-kappa B signaling pathway	2/134	104/8135	0.514	0.8694	0.8694	CSNK2A2/CFLAR	2
KEGG	hsa04620	Toll-like receptor signaling pathway	2/134	104/8135	0.514	0.8694	0.8694	IFNAR1/CTSK	2
KEGG	hsa04962	Vasopressin-regulated water reabsorption	1/134	44/8135	0.5194	0.8694	0.8694	AVP	1
KEGG	hsa04080	Neuroactive ligand-receptor interaction	6/134	353/8135	0.5282	0.8694	0.8694	TAC1/AVP/EDN1/SLURP1/NTS/PDYN	6
KEGG	hsa04530	Tight junction	3/134	169/8135	0.5302	0.8694	0.8694	MARVELD2/OCLN/PPP2R1B	3
KEGG	hsa04014	Ras signaling pathway	4/134	232/8135	0.5347	0.8694	0.8694	FGF5/BDNF/EFNA5/ARF6	4
KEGG	hsa03050	Proteasome	1/134	46/8135	0.5352	0.8694	0.8694	PSMB5	1
KEGG	hsa04010	MAPK signaling pathway	5/134	294/8135	0.5355	0.8694	0.8694	FGF5/RPS6KA1/BDNF/EFNA5/ATF4	5
KEGG	hsa04141	Protein processing in endoplasmic reticulum	3/134	171/8135	0.5382	0.8694	0.8694	HSPBP1/EDEM1/ATF4	3
KEGG	hsa00514	Other types of O-glycan biosynthesis	1/134	47/8135	0.5429	0.8694	0.8694	GALNT9	1
KEGG	hsa04973	Carbohydrate digestion and absorption	1/134	47/8135	0.5429	0.8694	0.8694	PLCB4	1
KEGG	hsa00565	Ether lipid metabolism	1/134	49/8135	0.5579	0.8807	0.8807	GDPD1	1
KEGG	hsa04020	Calcium signaling pathway	4/134	240/8135	0.5617	0.8807	0.8807	PLCB4/PHKG1/FGF5/CAMK2D	4
KEGG	hsa00510	N-Glycan biosynthesis	1/134	50/8135	0.5653	0.8807	0.8807	MGAT5	1
KEGG	hsa05144	Malaria	1/134	50/8135	0.5653	0.8807	0.8807	THBS3	1
KEGG	hsa01200	Carbon metabolism	2/134	115/8135	0.5685	0.8807	0.8807	ACO1/ACAT1	2
KEGG	hsa05152	Tuberculosis	3/134	180/8135	0.5732	0.8821	0.8821	RFXANK/CAMK2D/CEBPG	3
KEGG	hsa00600	Sphingolipid metabolism	1/134	52/8135	0.5795	0.8822	0.8822	SMPD1	1
KEGG	hsa04360	Axon guidance	3/134	182/8135	0.5807	0.8822	0.8822	TRPC4/CAMK2D/EFNA5	3
KEGG	hsa04935	Growth hormone synthesis, secretion and action	2/134	119/8135	0.5872	0.8823	0.8823	PLCB4/ATF4	2
KEGG	hsa04621	NOD-like receptor signaling pathway	3/134	184/8135	0.5882	0.8823	0.8823	IFNAR1/PLCB4/NAIP	3
KEGG	hsa05034	Alcoholism	3/134	187/8135	0.5992	0.8843	0.8843	PDYN/BDNF/ATF4	3
KEGG	hsa04340	Hedgehog signaling pathway	1/134	56/8135	0.6067	0.8843	0.8843	CCND2	1
KEGG	hsa05010	Alzheimer disease	6/134	384/8135	0.6116	0.8843	0.8843	NDUFA4L2/PLCB4/FZD10/PSMB5/CSNK2A2/ATF4	6
KEGG	hsa05134	Legionellosis	1/134	57/8135	0.6133	0.8843	0.8843	NAIP	1
KEGG	hsa04110	Cell cycle	2/134	126/8135	0.6185	0.8843	0.8843	CHEK2/CCND2	2
KEGG	hsa00480	Glutathione metabolism	1/134	58/8135	0.6197	0.8843	0.8843	GSTT2B	1
KEGG	hsa05213	Endometrial cancer	1/134	58/8135	0.6197	0.8843	0.8843	TCF7L2	1
KEGG	hsa05167	Kaposi sarcoma-associated herpesvirus infection	3/134	194/8135	0.6242	0.8843	0.8843	IFNAR1/RCAN1/TCF7L2	3
KEGG	hsa00230	Purine metabolism	2/134	128/8135	0.6271	0.8843	0.8843	PDE3A/AK9	2
KEGG	hsa05416	Viral myocarditis	1/134	60/8135	0.6322	0.8843	0.8843	SGCA	1
KEGG	hsa05130	Pathogenic Escherichia coli infection	3/134	197/8135	0.6346	0.8843	0.8843	OCLN/ARF6/NAIP	3
KEGG	hsa05012	Parkinson disease	4/134	266/8135	0.6434	0.8843	0.8843	NDUFA4L2/PSMB5/CAMK2D/ATF4	4
KEGG	hsa04510	Focal adhesion	3/134	201/8135	0.6482	0.8843	0.8843	VCL/CCND2/THBS3	3
KEGG	hsa00310	Lysine degradation	1/134	63/8135	0.6502	0.8843	0.8843	ACAT1	1
KEGG	hsa03250	Viral life cycle - HIV-1	1/134	63/8135	0.6502	0.8843	0.8843	BST2	1
KEGG	hsa04623	Cytosolic DNA-sensing pathway	1/134	63/8135	0.6502	0.8843	0.8843	CGAS	1
KEGG	hsa05415	Diabetic cardiomyopathy	3/134	203/8135	0.6548	0.8843	0.8843	NDUFA4L2/PLCB4/CAMK2D	3
KEGG	hsa05205	Proteoglycans in cancer	3/134	205/8135	0.6614	0.8843	0.8843	FZD10/ESR1/CAMK2D	3
KEGG	hsa05020	Prion disease	4/134	273/8135	0.6636	0.8843	0.8843	NDUFA4L2/PSMB5/CSNK2A2/ATF4	4
KEGG	hsa00010	Glycolysis / Gluconeogenesis	1/134	67/8135	0.6729	0.8843	0.8843	PCK1	1
KEGG	hsa04015	Rap1 signaling pathway	3/134	210/8135	0.6774	0.8843	0.8843	PLCB4/FGF5/EFNA5	3
KEGG	hsa05170	Human immunodeficiency virus 1 infection	3/134	212/8135	0.6836	0.8843	0.8843	BST2/AP1S3/CGAS	3
KEGG	hsa04920	Adipocytokine signaling pathway	1/134	69/8135	0.6836	0.8843	0.8843	PCK1	1
KEGG	hsa05204	Chemical carcinogenesis - DNA adducts	1/134	69/8135	0.6836	0.8843	0.8843	GSTT2B	1
KEGG	hsa04550	Signaling pathways regulating pluripotency of stem cells	2/134	143/8135	0.6869	0.8843	0.8843	FZD10/BMP4	2
KEGG	hsa05417	Lipid and atherosclerosis	3/134	215/8135	0.6928	0.8843	0.8843	PLCB4/CAMK2D/ATF4	3
KEGG	hsa05218	Melanoma	1/134	72/8135	0.6992	0.8843	0.8843	FGF5	1
KEGG	hsa00562	Inositol phosphate metabolism	1/134	73/8135	0.7042	0.8843	0.8843	PLCB4	1
KEGG	hsa01524	Platinum drug resistance	1/134	73/8135	0.7042	0.8843	0.8843	GSTT2B	1
KEGG	hsa04723	Retrograde endocannabinoid signaling	2/134	148/8135	0.705	0.8843	0.8843	NDUFA4L2/PLCB4	2
KEGG	hsa04514	Cell adhesion molecules	2/134	149/8135	0.7086	0.8843	0.8843	NLGN4Y/OCLN	2
KEGG	hsa01230	Biosynthesis of amino acids	1/134	75/8135	0.7139	0.8843	0.8843	ACO1	1
KEGG	hsa05214	Glioma	1/134	75/8135	0.7139	0.8843	0.8843	CAMK2D	1
KEGG	hsa05208	Chemical carcinogenesis - reactive oxygen species	3/134	223/8135	0.7164	0.8843	0.8843	NDUFA4L2/HMOX1/GSTT2B	3
KEGG	hsa00980	Metabolism of xenobiotics by cytochrome P450	1/134	78/8135	0.7279	0.8854	0.8854	GSTT2B	1
KEGG	hsa04612	Antigen processing and presentation	1/134	78/8135	0.7279	0.8854	0.8854	RFXANK	1
KEGG	hsa04932	Non-alcoholic fatty liver disease	2/134	155/8135	0.7289	0.8854	0.8854	NDUFA4L2/ATF4	2
KEGG	hsa01521	EGFR tyrosine kinase inhibitor resistance	1/134	79/8135	0.7325	0.8854	0.8854	EIF4EBP1	1
KEGG	hsa03010	Ribosome	2/134	158/8135	0.7387	0.8854	0.8854	RPS4Y2/RPS4Y1	2
KEGG	hsa04714	Thermogenesis	3/134	232/8135	0.7412	0.8854	0.8854	NDUFA4L2/RPS6KA1/COX19	3
KEGG	hsa05016	Huntington disease	4/134	306/8135	0.7483	0.8854	0.8854	NDUFA4L2/PLCB4/PSMB5/BDNF	4
KEGG	hsa05161	Hepatitis B	2/134	162/8135	0.7512	0.8854	0.8854	IFNAR1/ATF4	2
KEGG	hsa05206	MicroRNAs in cancer	4/134	310/8135	0.7574	0.8854	0.8854	HMOX1/CCND2/DDIT4/EFNA5	4
KEGG	hsa04610	Complement and coagulation cascades	1/134	85/8135	0.7581	0.8854	0.8854	CFB	1
KEGG	hsa04742	Taste transduction	1/134	86/8135	0.7621	0.8854	0.8854	PLCB4	1
KEGG	hsa05210	Colorectal cancer	1/134	86/8135	0.7621	0.8854	0.8854	TCF7L2	1
KEGG	hsa04512	ECM-receptor interaction	1/134	88/8135	0.77	0.8858	0.8858	THBS3	1
KEGG	hsa04540	Gap junction	1/134	88/8135	0.77	0.8858	0.8858	PLCB4	1
KEGG	hsa05032	Morphine addiction	1/134	91/8135	0.7813	0.888	0.888	PDE3A	1
KEGG	hsa04970	Salivary secretion	1/134	93/8135	0.7885	0.888	0.888	PLCB4	1
KEGG	hsa05323	Rheumatoid arthritis	1/134	93/8135	0.7885	0.888	0.888	CTSK	1
KEGG	hsa05150	Staphylococcus aureus infection	1/134	96/8135	0.7989	0.888	0.888	CFB	1
KEGG	hsa05414	Dilated cardiomyopathy	1/134	96/8135	0.7989	0.888	0.888	SGCA	1
KEGG	hsa04070	Phosphatidylinositol signaling system	1/134	97/8135	0.8023	0.888	0.888	PLCB4	1
KEGG	hsa04666	Fc gamma R-mediated phagocytosis	1/134	97/8135	0.8023	0.888	0.888	ARF6	1
KEGG	hsa01522	Endocrine resistance	1/134	98/8135	0.8055	0.888	0.888	ESR1	1
KEGG	hsa05231	Choline metabolism in cancer	1/134	98/8135	0.8055	0.888	0.888	EIF4EBP1	1
KEGG	hsa04061	Viral protein interaction with cytokine and cytokine receptor	1/134	100/8135	0.812	0.8887	0.8887	CXCL14	1
KEGG	hsa04914	Progesterone-mediated oocyte maturation	1/134	102/8135	0.8182	0.8887	0.8887	RPS6KA1	1
KEGG	hsa04972	Pancreatic secretion	1/134	102/8135	0.8182	0.8887	0.8887	PLCB4	1
KEGG	hsa04974	Protein digestion and absorption	1/134	103/8135	0.8212	0.8887	0.8887	DPP4	1
KEGG	hsa04062	Chemokine signaling pathway	2/134	192/8135	0.8297	0.8921	0.8921	PLCB4/CXCL14	2
KEGG	hsa05202	Transcriptional misregulation in cancer	2/134	193/8135	0.8319	0.8921	0.8921	SSX2B/CCND2	2
KEGG	hsa05169	Epstein-Barr virus infection	2/134	202/8135	0.8504	0.8997	0.8997	IFNAR1/CCND2	2
KEGG	hsa04724	Glutamatergic synapse	1/134	114/8135	0.8515	0.8997	0.8997	PLCB4	1
KEGG	hsa04726	Serotonergic synapse	1/134	115/8135	0.8539	0.8997	0.8997	PLCB4	1
KEGG	hsa05203	Viral carcinogenesis	2/134	204/8135	0.8543	0.8997	0.8997	CCND2/ATF4	2
KEGG	hsa04740	Olfactory transduction	5/134	440/8135	0.8579	0.8997	0.8997	RGS2/OR2B11/CAMK2D/OR2T33/OR5H15	5
KEGG	hsa04611	Platelet activation	1/134	124/8135	0.8745	0.913	0.913	PLCB4	1
KEGG	hsa04810	Regulation of actin cytoskeleton	2/134	218/8135	0.879	0.9137	0.9137	VCL/FGF5	2
KEGG	hsa04650	Natural killer cell mediated cytotoxicity	1/134	131/8135	0.8885	0.9195	0.9195	IFNAR1	1
KEGG	hsa00190	Oxidative phosphorylation	1/134	134/8135	0.894	0.9212	0.9212	NDUFA4L2	1
KEGG	hsa04371	Apelin signaling pathway	1/134	139/8135	0.9026	0.923	0.923	PLCB4	1
KEGG	hsa04120	Ubiquitin mediated proteolysis	1/134	142/8135	0.9074	0.923	0.923	CBLC	1
KEGG	hsa04936	Alcoholic liver disease	1/134	142/8135	0.9074	0.923	0.923	TCF7L2	1
KEGG	hsa04145	Phagosome	1/134	152/8135	0.9218	0.931	0.931	THBS3	1
KEGG	hsa01240	Biosynthesis of cofactors	1/134	153/8135	0.9231	0.931	0.931	AK9	1
KEGG	hsa05164	Influenza A	1/134	171/8135	0.9433	0.9473	0.9473	IFNAR1	1
KEGG	hsa04613	Neutrophil extracellular trap formation	1/134	190/8135	0.959	0.959	0.959	PLCB4	1